Publication|Videos|August 8, 2023
Solutions to Optimize Cell Therapy Development and Manufacturing
Author(s)Catalent
Catalent's Martin De Brauwere and Maria Lopez react to cell therapy innovations and highlight strategies to optimize the drug development and manufacturing process with assistance from a CDMO.
LEARN MORE IN THIS VIDEO:
- Current state of the cellular therapy market and challenges bringing newer therapies to commercialization
- Critical components tied to successful drug development and manufacturing of cell therapies
- Remaining current with regulatory guidance tied to cell therapies
- Proper oversight of supply chains tied to a cell therapy project
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
Cellares Scales IDMO Model for Gene-Edited Stem Cells Therapies
4
Women in STEM: Cultivating Scientific Confidence
5